Tuesday March 16, 8:30 am Eastern Time
Company Press Release
Veridien Corporation Announces 10SB12G Filed With SEC
ST. PETERSBURG, Fla.--(BUSINESS WIRE)--March 16, 1999--Veridien Corporation (OTC BB:VRDE - news), announced today the filing of Form 10SB12G with the U.S. Securities and Exchange Commission (SEC).
The document was filed electronically with the SEC by Bowne of Tampa, on March 12, 1999 at 15:51 Eastern Standard Time.
Veridien Corporation is focused to become a full-reporting company so that our investors may stay informed and bring more value to our Shareholders. Regulation S-B is the source of disclosure requirements for ''small business issuer'' (under $25,000,000 in revenue) filings under the Securities Act of 1933 and the Securities Exchange Act of 1934. The document is available to the Public through ''Edgar Online'' and through the SEC's Public Reference Room.
Veridien Corporation's flagship product VIRAHOL(r) is a patented, EPA registered, surface disinfectant, environmentally friendly and nontoxic by OSHA Standard 29 CFR 1910.1200, and is available in a variety of sizes for consumer and commercial applications. Additional Veridien products include VIRAGEL(r), a FDA regulated antiseptic hand gel in both consumer and commercial sizes and a FDA regulated first aid antiseptic spray also containing the patented VIRAHOL(r) composition.
Tomorrow's Products for Today
Look for us at businesswire.com
Special Note: Statements in this release are forward looking statements. There are a number of important factors that could cause actual events to differ materially from those indicated by such forward looking statements including market acceptance of, and demand for, the Company's products, manufacturing, development and distributor issues, product pricing, competition and other risks not identified herein. |
